Clozapine and lithium require Caenorhabditis elegans β-arrestin and serum- and glucocorticoid-inducible kinase to affect Daf-16 (Foxo) localization

Journal of Neuroscience Research

Volumn 89, Issue 10, 2011, Pages 1658-1665

  Weeks, Kathrine R ^a   Dwyer, Donard S ^b   Aamodt, Eric J ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

arrestin; Antipsychotic drugs; Clozapine; Lithium; SGK

Indexed keywords

BETA ARRESTIN; CAENORHABDITIS ELEGANS PROTEIN; CLOZAPINE; DEXAMETHASONE; GREEN FLUORESCENT PROTEIN; LITHIUM CHLORIDE; MESSENGER RNA; OLANZAPINE; PROTEIN KINASE B; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; TRANSCRIPTION FACTOR DAF 16; TRANSCRIPTION FACTOR FOXO; TRIFLUOPERAZINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; INTESTINE CELL; LARVA; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STARVATION; SUBCUTANEOUS TISSUE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; ARRESTINS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CLOZAPINE; FORKHEAD TRANSCRIPTION FACTORS; IMMEDIATE-EARLY PROTEINS; LITHIUM COMPOUNDS; MODELS, ANIMAL; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS;

EID: 79961210347     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22705     Document Type: Article

References (45)

1. Akam E, Strange PG. 2004. Inverse agonist properties of atypical antipsychotic drugs. Biochem Pharmacol 67: 2039-2045.
2. Avissar S, Schreiber G, Danon A, Belmaker RH. 1988. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331: 440-442.
3. Baldessarini R, Henk H, Sklar A, Chang J, Leahy L. 2008. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatr Serv 59: 1175-1183.
4. Bauer M, Dopfmer S. 1999. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J Clin Psychopharmacol 19: 427-434.
5. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. 2005. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122: 261-273.
6. Beaulieu JM, Marion S, Rodriguiz RM, Medvedev IO, Sotnikova TD, Ghisi V, Wetsel WC, Lefkowitz RJ, Gainetdinov RR, Caron MG. 2008. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 132: 125-136.
7. Bendz H, Aurell M. 1999. Drug-induced diabetes insipidus: incidence, prevention and management. Drug Saf 21: 449-456.
8. Brenner S. 1974. The genetics of Caenorhabditis elegans. Genetics 77: 71-94.
9. Busjahn A, Aydin A, Uhlmann R, Krasko C, Bahring S, Szelestei T, Feng Y, Dahm S, Sharma AM, Luft FC, Lang F. 2002. Serum- and glucocorticoid-regulated kinase (SGK1) gene and blood pressure. Hypertension 40: 256-260.
10. Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, Verrey F, Pearce D. 1999. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci U S A 96: 2514-2519.
11. Cipriani A, Pretty H, Hawton K, Geddes JR. 2005. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 162: 1805-1819.
12. Craddock N, Owen M. 2006. Genes for schizophrenia and bopolar disorder? Implications for psychiatric nosology. Schizophr Bull 32: 9-16.
13. Delva NJ, Letemendia FJ. 1982. Lithium treatment in schizophrenia and schizo-affective disorders. Br J Psychiatry 141: 387-400.
14. Donohoe DR, Phan T, Weeks K, Aamodt EJ, Dwyer DS. 2008a. Antipsychotic drugs up-regulate tryptophan hydroxylase in ADF neurons of Caenorhabditis elegans: role of calcium-calmodulin-dependent protein kinase II and transient receptor potential vanilloid channel. J Neurosci Res 86: 2553-2563.
15. Donohoe DR, Weeks K, Aamodt EJ, Dwyer DS. 2008b. Antipsychotic drugs alter neuronal development including ALM neuroblast migration and PLM axonal outgrowth in Caenorhabditis elegans. Int J Dev Neurosci 26: 371-380.
16. Dwyer DS, Donohoe D. 2003. Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake. Pharmacol Biochem Behav 75: 255-260.
17. Ertley RN, Bazinet RP, Lee HJ, Rapoport SI, Rao JS. 2007. Chronic treatment with mood stabilizers increases membrane GRK3 in rat frontal cortex. Biol Psychiatry 61: 246-249.
18. Fitzsimons J, Berk M, Lambert T, Bourin M, Dodd S. 2005. A review of clozapine safety. Expert Opin Drug Saf 4: 731-744.
19. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J. 2000. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408: 325-330.
20. Hertweck M, Gobel C, Baumeister R. 2004. C. elegans SGK-1 is the critical component in the Akt/PKB kinase complex to control stress response and life span. Dev Cell 6: 577-588.
21. Kane J, Honigfeld G, Singer J, Meltzer H. 1988. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45: 789-796.
22. Kawamoto H, Watanabe Y, Imaizumi T, Iwasaki T, Yoshida H. 1991. Effects of lithium ion on ADP ribosylation of inhibitory GTP-binding protein by pertussis toxin, islet-activating protein. Eur J Pharmacol 206: 33-37.
23. Klein PS, Melton DA. 1996. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 93: 8455-8459.
24. Krause M. 1995. Transcription and translation. Methods Cell Biol 48: 483-512.
25. Kumari S, Liu X, Nguyen T, Zhang X, D'Mello SR. 2001. Distinct phosphorylation patterns underlie Akt activation by different survival factors in neurons. Brain Res Mol Brain Res 96: 157-162.
26. Lu XH, Dwyer DS. 2005. Second-generation antipsychotic drugs olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K/AKT, ERK, and pertussis toxin-sensitive pathways. JMol Neurosci 27: 43-64.
27. Lu XH, Bradley RJ, Dwyer DS. 2004. Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38. Brain Res 1011: 58-68.
28. Luan B, Zhao J, Wu H, Duan B, Shu G, Wang X, Li D, Jia W, Kang J, Pei G. 2009. Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. Nature 457: 1146-1149.
29. McColl G, Killilea DW, Hubbard AE, Vantipalli MC, Melov S, Lithgow GJ. 2008. Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans. J Biol Chem 283: 350-357.
30. Muller-Oerlinghausen B, Felber W, Berghofer A, Lauterbach E, Ahrens B. 2005. The impact of lithium long-term medication on suicidal behavior and mortality of bipolar patients. Arch Suicide Res 9: 307-319.
31. Palmitessa A, Benovic JL. 2010. Arrestin and the multi-PDZ domain-containing protein MPZ-1 interact with phosphatase and tensin homolog (PTEN) and regulate Caenorhabditis elegans longevity. J Biol Chem 285: 15187-15200.
32. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
33. Ringstad N, Abe N, Horvitz HR. 2009. Ligand-gated chloride channels are receptors for biogenic amines in C. elegans. Science 325: 96-100.
34. Robbins MJ, Critchlow HM, Lloyd A, Cilia J, Clarke JD, Bond B, Jones DN, Maycox PR. 2008. Differential expression of IEG mRNA in rat brain following acute treatment with clozapine or haloperidol: a semi-quantitative RT-PCR study. J Psychopharmacol 22: 536-542.
35. Seachrist JL, Ferguson SS. 2003. Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases. Life Sci 74: 225-235.
36. Soares JC, Gershon S. 1998. The lithium ion: a foundation for psychopharmacological specificity. Neuropsychopharmacology 19: 167-182.
37. Stambolic V, Ruel L, Woodgett JR. 1996. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6: 1664-1668.
38. Sulston JE, Hodgkin JA. 1988. Methods 587-606. In: Wood WB and the community of C. elegans researchers, editors. The nematode Caenorhabditis elegans. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
39. Takada K, Tada H, Takano T, Nishiyama S, Amino N. 1993. Functional regulation of GTP-binding protein coupled to insulin-like growth factor-I receptor by lithium during G1 phase of the rat thyroid cell cycle. FEBS Lett 318: 245-248.
40. Vestergaard P, Amdisen A, Schou M. 1980. Clinically significant side effects of lithium treatment. A survey of 237 patients in long-term treatment. Acta Psychiatr Scand 62: 193-200.
41. von Wowern F, Berglund G, Carlson J, Mansson H, Hedblad B, Melander O. 2005. Genetic variance of SGK-1 is associated with blood pressure, blood pressure change over time and strength of the insulin-diastolic blood pressure relationship. Kidney Int 68: 2164-2172.
42. Wahlbeck K, Cheine M, Essali A, Adams C. 1999. Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psychiatry 156: 990-999.
43. Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL. 1993. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 13: 2031-2040.
44. Weeks KR, Dwyer DS, Aamodt EJ. 2010. Antipsychotic drugs activate the C. elegans Akt pathway via the DAF-2 insulin/IGF-1 receptor. ACS Chem Neurosci 1: 463-473.
45. Woo YS, Kim W, Chae JH, Yoon BH, Bahk WM. 2009. Blood pressure changes during clozapine or olanzapine treatment in Korean schizophrenic patients. World J Biol Psychiatry 10: 420-425.